Literature DB >> 29465686

Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women.

Collin M Price, Remco P H Peters, Janré Steyn, Maanda Mudau, Dawie Olivier, Lindsey De Vos, Erika Morikawa, Marleen M Kock, Andrew Medina-Marino, Jeffrey D Klausner.   

Abstract

BACKGROUND: Trichomonas vaginalis is a sexually transmitted infection associated with increased transmission of HIV and significant adverse birth outcomes; culture and polymerase chain reaction (PCR) are commonly used in diagnosis.
METHODS: Consenting HIV-infected pregnant women were recruited from clinics in South Africa and screened for T. vaginalis using PCR. Polymerase chain reaction-positive women provided an additional sample for culture. We compared T. vaginalis detection between PCR and culture, and investigated how PCR cycle threshold (Ct) values differ among culture results.
RESULTS: A total of 359 women were enrolled and 76 (20%) tested T. vaginalis PCR positive. Cultures were obtained from 61 of the PCR-positive women, and 38 (62%) were culture positive. The median baseline Ct of the PCR-positive/culture-positive group was 22.6 versus 38.0 among those who were PCR positive/culture negative (P < 0.001). Culture-positive cases had lower Ct values (higher DNA load); a Ct value less than 30 predicted positivity with a sensitivity of 97% and a specificity of 96%.
CONCLUSIONS: Culture was positive in roughly half of PCR-positive cases. The culture-negative cases had significantly higher Ct values, indicating a lower concentration of T. vaginalis DNA. A Ct value of 30 provides a reliable threshold for predicting culture positivity. The clinical significance of culture-negative infections detected by PCR is still unclear.

Entities:  

Mesh:

Year:  2018        PMID: 29465686      PMCID: PMC5897177          DOI: 10.1097/OLQ.0000000000000756

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  21 in total

1.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Authors:  Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

2.  Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: prevalence, risk factors, and association with low birth weight.

Authors:  M Y Sutton; M Sternberg; M Nsuami; F Behets; A M Nelson; M E St Louis
Journal:  Am J Obstet Gynecol       Date:  1999-09       Impact factor: 8.661

3.  Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic.

Authors:  D Wilkinson; S S Abdool Karim; A Harrison; M Lurie; M Colvin; C Connolly; A W Sturm
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

4.  Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women.

Authors:  James A Williams; Susan Ofner; Byron E Batteiger; J Dennis Fortenberry; Barbara Van Der Pol
Journal:  Sex Transm Dis       Date:  2014-03       Impact factor: 2.830

5.  Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid.

Authors:  Joshua R Mann; Suzanne McDermott; Tariq Gill
Journal:  J Matern Fetal Neonatal Med       Date:  2010-06

Review 6.  Trichomoniasis and HIV interactions: a review.

Authors:  Patricia Kissinger; Alys Adamski
Journal:  Sex Transm Infect       Date:  2013-04-20       Impact factor: 3.519

Review 7.  Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis.

Authors:  Bronwyn J Silver; Rebecca J Guy; John M Kaldor; Muhammad S Jamil; Alice R Rumbold
Journal:  Sex Transm Dis       Date:  2014-06       Impact factor: 2.830

8.  Viability-PCR Shows That NAAT Detects a High Proportion of DNA from Non-Viable Chlamydia trachomatis.

Authors:  Kevin J H Janssen; Christian J P A Hoebe; Nicole H T M Dukers-Muijrers; Lisanne Eppings; Mayk Lucchesi; Petra F G Wolffs
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

Review 9.  Polymerase chain reaction-based assays for the diagnosis of human brucellosis.

Authors:  Ying Wang; Zhanli Wang; Yaxian Zhang; Liyun Bai; Yue Zhao; Chunfang Liu; An Ma; Hui Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-08-01       Impact factor: 3.944

10.  Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study.

Authors:  Dewi J de Waaij; Jan Henk Dubbink; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  BMJ Open       Date:  2017-10-08       Impact factor: 2.692

View more
  7 in total

1.  Detection of metronidazole resistance in Trichomonas vaginalis using uncultured vaginal swabs.

Authors:  Bongekile Ngobese; Ravesh Singh; Khine Swe Swe- Han; Partson Tinarwo; Nonkululeko Mabaso; Nathlee S Abbai
Journal:  Parasitol Res       Date:  2022-06-03       Impact factor: 2.383

2.  Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial.

Authors:  Andrew Medina-Marino; Susan Cleary; Christina A Muzny; Christopher Taylor; Ashutosh Tamhane; Phuti Ngwepe; Charl Bezuidenhout; Shelley N Facente; Koleka Mlisana; Remco P H Peters; Jeffrey D Klausner
Journal:  Trials       Date:  2022-05-24       Impact factor: 2.728

Review 3.  A review on Trichomonas vaginalis infections in women from Africa.

Authors:  Nonkululeko Mabaso; Nathlee S Abbai
Journal:  S Afr J Infect Dis       Date:  2021-06-10

Review 4.  Galectins as potential therapeutic targets in STIs in the female genital tract.

Authors:  Agustin L Lujan; Diego O Croci; Gabriel A Rabinovich; Maria T Damiani
Journal:  Nat Rev Urol       Date:  2022-02-01       Impact factor: 14.432

Review 5.  Sexually transmitted infections in pregnant women from sub-Saharan Africa.

Authors:  Bongekile Ngobese; Nathlee S Abbai
Journal:  S Afr J Infect Dis       Date:  2021-12-09

Review 6.  Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection.

Authors:  Olivia T Van Gerwen; Christina A Muzny
Journal:  F1000Res       Date:  2019-09-20

7.  Persistent Chlamydia trachomatis, Neisseria gonorrhoeae or Trichomonas vaginalis positivity after treatment among human immunodeficiency virus-infected pregnant women, South Africa.

Authors:  Andrew Medina-Marino; Maanda Mudau; Noah Kojima; Remco Ph Peters; Ute D Feucht; Lindsey De Vos; Dawie Olivier; Christina A Muzny; James A McIntyre; Jeffrey D Klausner
Journal:  Int J STD AIDS       Date:  2020-02-23       Impact factor: 1.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.